Related Experiment Video
Updated: Jul 10, 2026
06:27
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
High-resolution structure of monomorphic Aβ1-40 fibrils
Salima Bahri1, Ravi Shankar Palani1, Robert Silvers2
1Department of Chemistry and Francis Bitter Magnet Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139.
Summary
Researchers developed a method to create pure amyloid-beta (Aβ) fibrils, revealing their detailed structure using NMR. This provides a key reference for Alzheimer's disease research.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Amyloid-beta (Aβ) fibrils, particularly Aβ₁₋₄₀ and Aβ₁₋₄₂, are central to Alzheimer's disease pathology.
- Polymorphism in Aβ₁₋₄₀ fibril structures, due to preparation methods, hinders detailed structural analysis.
Purpose of the Study:
- To establish a reliable structural baseline for amyloid-beta (Aβ)₁₋₄₀ fibrils.
- To characterize the high-resolution structure of monomorphic Aβ₁₋₄₀ fibrils formed under physiological conditions.
Main Methods:
- Recombinant expression and purification of Aβ₁₋₄₀.
- Magic-angle spinning (MAS) NMR spectroscopy for structural determination.
- Small-angle X-ray scattering (SAXS) for fibril cross-section analysis.
Main Results:
- A protocol yielding monomorphic Aβ₁₋₄₀ fibrils at pH 7.4 was established.
- A high-resolution fibril structure (PDB ID 12GB) was determined, showing two monomers per filament plane with distinct β-sheets and three hydrophobic cores.
- SAXS data supported a two-filament arrangement with four monomers per fibril plane.
Conclusions:
- The study provides an atomic-resolution structure of monomorphic Aβ₁₋₄₀ fibrils, serving as a crucial reference.
- Understanding this structure aids in elucidating the mechanisms of amyloid fibril formation in Alzheimer's disease.
- The findings facilitate the development of targeted therapeutic strategies against amyloid aggregation.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...